Addendum Number 3 of the “Up to USD 7,100,000 Credit Facilites Agreement” of ___ October 2020 betweenCredit Facilities Agreement • October 19th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2020 Company Industry
Amendment of the Convertible Loan Agreement of betweenConvertible Loan Agreement • October 19th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2020 Company Industry
Amendment of the convertible Loan AGREEMENT _________________________________________________________ (“Amendment”) of ___________________ between NLSPharmaCEUTICS AG as Borrower and […] as Lender each a “Party”, together the “Parties”Convertible Loan Agreement • October 19th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2020 Company IndustryWHEREAS Section 4 of the Convertible Loan Agreement sets forth that the Borrower may at its own and entire discretion repay the loan with accrued interests, if any, starting December 23 2020 (“Conversion Date Borrower”).
Series A Loan Agreement of betweenSeries a Loan Agreement • October 19th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2020 Company Industry
Amendment Series A Loan Agreement of betweenSeries a Loan Agreement • October 19th, 2020 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations
Contract Type FiledOctober 19th, 2020 Company Industry